The Global CEO Initiative on Alzheimer's Disease

CEOi brings business leadership to the global fight against Alzheimer’s – a growing pandemic.

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

Check out the terrific work @familydoctor is doing to support primary care physicians and their patients' cognitive health needs!

[familydoctor.org @familydoctor]

Doctors now have more tools to support cognitive health, like blood tests that look for Alzheimer’s markers.

💬 Talk to your doctor if you’ve noticed changes in memory, thinking or focus.

For more information on Alzheimer's: https://t.co/cY5DhL0xUX

[AAFP @aafp]

Improve early detection of Alzheimer’s and related dementias through early detection and intervention with the latest insights into blood-based biomarkers: https://t.co/6zA7Atdrmt

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

CEOi launches the first-ever Alzheimer’s Blood Test Performance Database! A game-changer for clinicians evaluating diagnostic tools.

Explore now: https://t.co/2GkYrLcObB

#Alzheimers #BloodTests #Diagnostics

[Health Policy Watch @HealthPolicyW]

Putting the ‘Brain Economy’ on the Map of Global Health Priorities 
https://t.co/opK3edrHRH

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

In our latest podcast, we explore how Alzheimer’s blood tests are being integrated into primary care. A must-listen for clinicians on the forefront of diagnosis! https://t.co/oOfp9mU0q4

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

Alzheimer’s blood tests are revolutionizing diagnosis, and PCP’s are key to their adoption. Dive into this episode to explore their role in enhancing patient care in our new podcast with Pri-Med. Listen now: https://t.co/oOfp9mU0q4

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

CEOi & Pri-Med launch a 3-episode podcast series on Alzheimer’s blood tests! Dive into the latest science, practical insights, & ethical considerations with expert guests. Elevate your practice today: https://t.co/oOfp9mU0q4

Thanks to our amazing guests!

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

New Report Launch! The Alzheimer’s Prevention Accelerator outlines a roadmap for tackling Alzheimer’s globally, with a focus on prevention, innovation, and collaboration. Join us in shaping the future of brain health.

Read more: https://t.co/OZr0ZueH0K

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

"Now is a great time to be in Alzheimer’s research," says Dr. Chi-Udeh Momoh. She and Dr. Mielke are pioneering blood tests that are transforming diagnosis & treatment. Learn more about the work they led for CEOi’s BBM workgroup on our site!

https://t.co/1oZn8RN2TT

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

Check out our landmark publications in @alzdemjournals! We're excited to share two peer-reviewed articles on blood tests for Alzheimer’s:

Our Workgroup outlines crucial steps to make Alzheimer’s blood tests more accessible. Read the recommendations: https://t.co/oEYYdvGNti

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

Thank you to @UsAgainstAlz for promoting the amazing work of our Blood-baed Biomarker Workgroup.

Together we're revolutionizing the Alzheimer's diagnosis process!

[UsAgainstAlzheimer's @UsAgainstAlz]

.@CEOi_Alz announced a key milestone in Alzheimer's diagnosis this morning in two peer-reviewed papers from their Blood-based Biomarket Workgroup, published in the @alzdemjournals.

Learn more here: https://t.co/OjcfKWKXG4

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

CEOi is excited to announce a key milestone in Alzheimer’s diagnosis with the publication of two peer-reviewed papers in @alzdemjournals from our Blood-based Biomarker Workgroup. Learn more about how these tests can be integrated into clinical practice https://t.co/ExCvMdvIGn

[Mount Sinai Neurology @MSHSNeurology]

Excited that @MountSinaiNYC is among the first to offer blood-based biomarkers for early Alzheimer’s detection! Co-led by @FannyElahi & Dr. Georges Naasan, this @DavosAlzheimers project could revolutionize Alzheimer’s care.
https://t.co/0x8iAJJEAy

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

We're honored to be featured in Being Patient's latest article about AAIC 2024. Thanks again to everyone who attended our panel and luncheon discussion!

https://t.co/e6AzRymtjK
#AAIC #Alzheimers #Alzheimersresearch

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

CEOi is delighted to celebrate this incredible news!

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

For years, Alzheimer's could only be diagnosed through an autopsy. Now, blood tests are revolutionizing diagnostics! Thanks to Suzanne Schindler and our workgroup, we've set standards published in @NatureRevNeurol. Learn more: https://t.co/xJmwOHvyuJ https://t.co/MOtdD6X2K2

[Eisai U.S. Neurology @eisaiusneuro]

We’re supporting advancements in Alzheimer’s care with the publication of @CEOi_Alz BBM Workgroup’s recommendations for blood-based biomarker (BBM) tests in @NatRevNeurol. Read more: https://t.co/0vm7tiyD2k

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

We've published the 1st performance recommendations for blood-based biomarker tests for Alzheimer’s disease in Nature Reviews Neurology. These landmark standards will help inform the appropriate and effective use of BBM tests in clinical practice!
https://t.co/VdtWCELMPR

[The Global CEO Initiative on Alzheimer's Disease @CEOi_Alz]

CEOi would like to welcome our newest member organization @bmsnews to our growing network. We look forward to joining forces in the fight against #Alzheimers!

[Davos Alzheimer’s Collaborative @DavosAlzheimers]

Following the DAC Healthcare System Preparedness #LearningLaboratory on the power of technology in #Alzheimers early detection, read DAC's call for key actions to expand Alzheimer's early detection and strengthen healthcare system preparedness globally: https://t.co/yHK7TRESC5